









Mercado
/
Acciones
/
nasdaq-atrc
/

AtriCure Inc

ATRC

35.860USD

+1.450+4.21%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

1.78BCap. mercado

PérdidaP/E TTM



AtriCure Inc

35.860

+1.450+4.21%

Descripción general Compañía Finanzas

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Información de la empresa

Símbolo de cotizaciónATRC

Nombre de la empresaAtriCure Inc

Fecha de salida a bolsaAug 05, 2005

Director ejecutivoMr. Michael H. (Mike) Carrel, CPA

Número de empleados1300

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 05

Dirección7555 Innovation Way

CiudadMASON

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal45040

Teléfono15137554100

Sitio Webhttps://www.atricure.com

Símbolo de cotizaciónATRC

Fecha de salida a bolsaAug 05, 2005

Director ejecutivoMr. Michael H. (Mike) Carrel, CPA

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Ms. Regina E. (Reggie) Groves

Independent Director

36.17K

+17.56%

Mr. Sven A. Wehrwein, CPA

Independent Director

34.37K

+18.64%

Ms. Deborah H. (Deb) Telman

Independent Director

22.18K

+32.18%

Mr. Shlomo Nachman

Independent Director

18.51K

+41.20%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael H. (Mike) Carrel, CPA

President, Chief Executive Officer, Director

718.94K

+0.11%

Mr. Salvatore Privitera, J.D.

Chief Technical Officer

125.59K

+0.66%

Mr. Robert S. (Bob) White

Independent Chairman of the Board

92.17K

+20.06%

Mr. Justin J. Noznesky

Chief Marketing and Strategy Officer

86.96K

+23.01%

Dr. Vinayak Doraiswamy, Ph.D.

Chief Scientific Officer

74.37K

+1.12%

Mr. Karl S. Dahlquist, J.D.

Chief Legal Officer

68.55K

+1.21%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

101.15M

81.82%

Europe

14.20M

11.49%

Asia

6.78M

5.49%

Other international

1.49M

1.20%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Appendage Management-United states

42.09M

34.05%

Open Ablation - United states

33.31M

26.94%

Pain management

17.27M

13.97%

Appendage management -International

9.67M

7.83%

Open ablation -International

8.99M

7.28%

Other

12.28M

9.94%

Estadísticas de accionistas

Actualizado: mar., 20 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

Accionistas

Proporción

The Vanguard Group, Inc.

9.46%

AllianceBernstein L.P.

7.40%

BlackRock Institutional Trust Company, N.A.

7.19%

Hood River Capital Management LLC

6.03%

Macquarie Investment Management

4.90%

Other

65.02%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

56.65%

Investment Advisor/Hedge Fund

33.71%

Hedge Fund

10.66%

Individual Investor

3.55%

Research Firm

1.93%

Pension Fund

0.75%

Bank and Trust

0.50%

Sovereign Wealth Fund

0.23%

Family Office

0.07%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

531

53.52M

108.11%

-4.10M

2025Q1

544

53.44M

107.95%

-4.07M

2024Q4

526

50.00M

102.31%

-11.07M

2024Q3

522

53.78M

110.47%

-8.64M

2024Q2

511

54.11M

111.85%

-4.03M

2024Q1

517

53.02M

109.65%

-1.47M

2023Q4

515

50.20M

105.93%

-1.70M

2023Q3

504

48.87M

103.22%

-3.82M

2023Q2

499

48.88M

103.48%

-3.46M

2023Q1

503

48.62M

102.63%

-1.48M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

4.70M

9.5%

+61.17K

+1.32%

Mar 31, 2025

AllianceBernstein L.P.

3.68M

7.43%

-158.60K

-4.14%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.57M

7.21%

-92.41K

-2.52%

Mar 31, 2025

Hood River Capital Management LLC

3.00M

6.06%

+75.48K

+2.58%

Mar 31, 2025

Macquarie Investment Management

2.44M

4.92%

+61.60K

+2.59%

Mar 31, 2025

Champlain Investment Partners, LLC

2.14M

4.32%

-390.65K

-15.45%

Mar 31, 2025

Two Sigma Investments, LP

1.33M

2.68%

+75.83K

+6.06%

Mar 31, 2025

First Light Asset Management, LLC

1.31M

2.66%

-654.50K

-33.24%

Mar 31, 2025

State Street Global Advisors (US)

1.28M

2.58%

-68.53K

-5.09%

Mar 31, 2025

UBS Asset Management (Switzerland)

1.26M

2.54%

+537.08K

+74.31%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 2 de ago

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.81%

Harbor Human Capital Factor US Small Cap ETF

0.76%

NYLI Healthy Hearts ETF

0.47%

First Trust Small Cap Growth AlphaDEX Fund

0.45%

Invesco NASDAQ Future Gen 200 ETF

0.43%

Amplify Etho Climate Leadership U.S. ETF

0.3%

JPMorgan Fundamental Data Science Small Core ETF

0.26%

Franklin US Small Cap Multifactor Index ETF

0.25%

First Trust Small Cap Core Alphadex Fund

0.24%

iShares U.S. Medical Devices ETF

0.18%

SPDR S&P Health Care Equipment ETF

Proporción1.81%

Harbor Human Capital Factor US Small Cap ETF

Proporción0.76%

NYLI Healthy Hearts ETF

Proporción0.47%

First Trust Small Cap Growth AlphaDEX Fund

Proporción0.45%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.43%

Amplify Etho Climate Leadership U.S. ETF

Proporción0.3%

JPMorgan Fundamental Data Science Small Core ETF

Proporción0.26%

Franklin US Small Cap Multifactor Index ETF

Proporción0.25%

First Trust Small Cap Core Alphadex Fund

Proporción0.24%

iShares U.S. Medical Devices ETF

Proporción0.18%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

